Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04568993Active, not recruiting
Randomised, open-label trial of methylprednisolone and lidocaine in trigger finger and trigger thumb (2 arms), sponsored by Sahlgrenska University Hospital. Primary endpoints: Pain after injection at 4 weeks, Impairment of finger motion at 4 weeks and 1 more. Started Oct 2020; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04568993.